Debiganto 150mg Tablet
Prescription Required
Product introduction
Debiganto 150mg Tablet is an anticoagulant or blood thinner. It helps prevent and treat blood clots. It is used to reduce the risk of stroke and heart attack. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart.
Debiganto 150mg Tablet is a medicine which makes your blood flow more easily. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart. It is used in patients with irregular heart rhythm (atrial fibrillation). It reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. Side effect of this medicine is that you can bleed too easily. Hence, it is advisable to use it with utmost care in conditions involving increased risk of bleeding. Unlike other anti-coagulants, regular blood test (PT-INR) is not required while taking this medicine.
Debiganto 150mg Tablet is a medicine which makes your blood flow more easily. It prevents and treats clot formation in the veins of your legs, lungs, brain, and heart. It is used in patients with irregular heart rhythm (atrial fibrillation). It reduces the risk of getting clots in people who have undergone knee or hip replacement surgeries. Side effect of this medicine is that you can bleed too easily. Hence, it is advisable to use it with utmost care in conditions involving increased risk of bleeding. Unlike other anti-coagulants, regular blood test (PT-INR) is not required while taking this medicine.
Uses of Debiganto Tablet
- Treatment and prevention of Blood clots
Benefits of Debiganto Tablet
In Treatment and prevention of Blood clots
Debiganto 150mg Tablet is a type of medicine known as an anticoagulant. Although it does not “dissolve” blood clots, it can prevent them from getting bigger so your body can dissolve them over time. It will also prevent new ones from forming. It works by blocking a substance in the body which is involved in blood clotting. This keeps your blood flowing freely around your body and makes it less likely that a clot will form inside a blood vessel. This can help prevent or reduce damage caused by stroke, clots in your lungs (pulmonary embolism), or other blood vessels (thrombosis). It can also make it less likely that parts of a clot will break off and travel to other parts of the body. You should take it regularly and make appropriate lifestyle changes to help this medicine be effective.
Side effects of Debiganto Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Debiganto
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Debiganto Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Debiganto 150mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Debiganto 150mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Debiganto 150mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Debiganto 150mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Debiganto 150mg Tablet does not usually affect your ability to drive.
Kidney
CAUTION
Debiganto 150mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Debiganto 150mg Tablet may be needed. Please consult your doctor.
Use of Debiganto 150mg Tablet is not recommended in patients with severe kidney disease.
Use of Debiganto 150mg Tablet is not recommended in patients with severe kidney disease.
Liver
CAUTION
Debiganto 150mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Debiganto 150mg Tablet may be needed. Please consult your doctor.
What if you forget to take Debiganto Tablet?
If you missed a dose of Debiganto 150mg Tablet, take it as soon as possible on the same day. The missed dose should be skipped if it cannot be taken at least 6 hours before the next scheduled dose. Do not double the dose to make up for a missed dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Debiganto 150mg Tablet
₹61.2/Tablet
Bigatra 150mg Tablet
Aprica Pharmaceuticals Pvt Ltd
₹35/tablet
38% cheaper
Dabmit 150mg Tablet
Mits Healthcare Pvt Ltd
₹43.1/tablet
23% cheaper
Dabihart 150mg Tablet
Leeford Healthcare Ltd
₹36.8/tablet
35% cheaper
Dabirest 150mg Tablet
Trumac Healthcare
₹45/tablet
20% cheaper
Quick tips
- Take it as per dose and duration suggested by your doctor.
- Debiganto 150mg Tablet increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails, using sharp objects or engaging in contact sports (e.g., football and wrestling).
- If you are going to have a surgery or dental treatment, you may be asked to stop taking Debiganto 150mg Tablet temporarily.
- Your doctor may get a blood test done to check kidney function before starting treatment with this medicine.
- Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.
- Do not stop taking the medication without talking to your doctor.
Fact Box
Chemical Class
Benzimidazole derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Direct thrombin inhibitor- oral
Patient concerns
FAQs
When should I take Debiganto 150mg Tablet?
Mostly, Debiganto 150mg Tablet is suggested to be taken twice daily at the same time each day. The two doses should be taken at a gap of about 12 hours.
Can I drink alcohol with Debiganto 150mg Tablet?
Taking alcohol while taking Debiganto 150mg Tablet can increase the effect of this medicine, thereby increasing the chance of bleeding. Regular intake of alcohol can lead to a gastric ulcer which might again cause bleeding. So, it is better to avoid alcohol while you are taking this medicine. Do consult your doctor if any such episode of bleeding occurs.
Can Debiganto 150mg Tablet cause hair loss?
As compared to other blood-thinning medications, Debiganto 150mg Tablet does not usually cause hair loss. However, there do exist some rare reports of hair loss associated with Debiganto 150mg Tablet. Consult your doctor if you face hair loss while taking Debiganto 150mg Tablet to rule out any other causes of hair loss.
When will I feel better after taking Debiganto 150mg Tablet?
Debiganto 150mg Tablet reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Debiganto 150mg Tablet. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
Does Debiganto 150mg Tablet affect the liver?
Unlike other anticoagulants, Debiganto 150mg Tablet usually does not affect the functioning of the liver. But long-term use of Debiganto 150mg Tablet may increase the chances of mild liver injury in patients with elevated liver enzymes. However, the overall chances of developing any such problem are lower than other anticoagulants. It is advised that you inform your doctor if you have a history of liver disease before starting this medicine.
How should I store Debiganto 150mg Tablet?
Debiganto 150mg Tablet should be stored at room temperature between 59°F to 86°F (15°C to 30°C). Store the medicine at a dry place and protect the capsules from moisture. Close the bottle tightly after use and keep it out of the reach of children. Once the bottle is opened, it should be used within 4 months. If unused within 4 months, please discard them safely.
Can the use of Debiganto 150mg Tablet increase the risk of bleeding?
Yes, Debiganto 150mg Tablet increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
Who should not take Debiganto 150mg Tablet?
People experiencing any unusual bleeding or people allergic to Debiganto 150mg Tablet should not take it. Debiganto 150mg Tablet should also be avoided by people with artificial (prosthetic) heart valves. Therefore, inform your doctor if you have ever had or plan to have a valve in your heart replaced.
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 865-66.
- Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 594.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 346-47.
- Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 363-65.
Marketer details
Name: Shinto Organics (P) Limited
Address: 110, Industrial Area, Phase-II, Panchkula (Haryana) - 134113
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹612
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT